ARO-ALK7

N/A

Report date: 2026/04/14 20:00:15
NME

Base Information

Drug NameARO-ALK7
Drug Alias NameARO ALK7ARO-ALK7
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionActivin receptor type-1C inhibitorsRNA interference
TargetsActivin receptor type-1C
Therapy Area/IndicationsObesityDiabetes Mellitus, Type 2Metabolic Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesNew ZealandAustralia
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesArrowhead Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesArrowhead Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsObesityDiabetes Mellitus, Type 2Metabolic Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A